|
Kou Hao, Associate Professor, Associate Chief Pharmacist, Master's Supervisor
Wuhan University , Medical School
Area of Focus
Pharmacogenomics | Personalized Medication | Drug Safety | Genetic Profiling | Medication Therapy Management | Toxicology | Drug Development | Clinical Pharmacology | Molecular Biology | Bioinformatics |
|
Ji Yanxiao, Distinguished Researcher
Wuhan University , Medical School
Area of Focus
Post-Translational | Metabolic Diseases | Mechanisms | Protein Modification | Drug Development | Antibodies | Small Molecules | Target-Based | Therapeutics | Biochemistry |
|
Lei Han, Professor, Doctoral/Master's Supervisor, National Talent Program Awardee
Wuhan University , Medical School
Area of Focus
Transmembrane | Transport Proteins | Drug Development | Substrate Transport | Protein Conformation | Membrane Potential | Metabolic Transport | Disease Relation | Structural Biology | High-Throughput Screening |
|
Xiaojing Zhang, Distinguished Researcher
Wuhan University , Medical School
Area of Focus
Liver Injury | Drug Development | Chronic Liver Disease | Acute Liver Disease | Non-Alcoholic Fatty Liver Disease | Liver Metabolism | Ischemia-Reperfusion | Multi-Organ Damage | Pathological Mechanisms | Therapeutic Targets |
|
Jing Chen, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Metabolic Diseases | Pharmacology | Drug Development | Liver Diseases | Diabetes | Obesity | Non-Alcoholic Fatty Liver Disease | Fibrosis | Micrornas | Lipid Metabolism |
|
Yuanyuan Li, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Metabolic Diseases | Non-Alcoholic Fatty Liver Disease | Liver Fibrosis | Pharmacology | Liver Disease | Metabolism | Hepatology | Cell Signaling | Drug Development | Biomedical Research |
|
Shibing Tang, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Malignant Tumors | Metabolic Diseases | Drug Development | Bioactive Molecules | Tool Molecules | Synthesis | Process Optimization | Small Molecule Drugs | Preclinical Research | Innovative Drug Discovery |
|
Yi Li, Doctoral Supervisor
University of Chinese Academy of Sciences , Medical School
Area of Focus
Anti-Tumor | Metabolic Diseases | Drug Development | Innovation | Research | Pharmaceuticals | Oncology | Metabolism | Therapeutics | Biochemistry |
